A Message from the President
Dear Colleagues,
The Journal for ImmunoTherapy of Cancer (JITC) is the Society for Immunotherapy of Cancer’s (SITC) official journal. The journal publishes articles on all aspects of tumor immunology and cancer immunotherapy and, in doing so, aims to enrich communication and advance scientific understanding among the many stakeholders in this rapidly evolving field. The meteoric success of JITC since its inception nine years ago is unprecedented.
Leading the charge of this increasingly prestigious publication is Editor-in-Chief, Dr. Pedro Romero, MD, Head, Div. of Clinical Onco-Immunology, University of Lausanne & University Hospital of Lausanne. I had the pleasure of hosting Dr. Romero who is a long-term SITC member and who has served as Editor-in-Chief of JITC for nearly 10 years. He has helped to grow the journal from a relatively small online publication to one that now boasts a Journal Impact Factor greater than 13 and Scimago Journal Rank over 5.
I thoroughly enjoyed our conversation and the glimpse into his background and achievements. From realizing his passion for science at a young age in Columbia to his research activities with peptide vaccines and immune biomarkers to what is currently on his music playlist, we covered a host of topics in this latest fireside chat.
Thank you very much to Dr. Romero – a true pillar of the tumor immunology field – for joining me this month.
Sincerely,
Patrick Hwu, MD
SITC President
Join Us at SITC 2021 This November in Washington, D.C. or Virtually
Exhibiting and Sponsorship
SITC offers a number of ways to promote your product or service. SITC 2021 will be presented as a hybrid meeting, which means we have innovative in-person and virtual solutions to meet your marketing and branding needs.
Contact development@sitcancer.org or (414) 271-2456 for more information and to discuss customization options.
Register Now for SITC Virtual Fall Programs
Interrogating the Tumor-Specific Surfaceome for Immune Targeting Virtual Workshop
Sept. 29–30, 2021 · Register Now · Program Schedule
Program Organizers
- Samir M. Hanash, MD, PhD – The University of Texas MD Anderson
- Avery D. Posey Jr., PhD – University of Pennsylvania School of Medicine
Bispecific T cell Engagers Virtual Workshop
Sept. 30–Oct. 1, 2021 · Register Now· Program Schedule
Program Organizers
- Elizabeth Budde, MD, PhD – City of Hope
- Daniel S. Chen, MD, PhD
- James L. Gulley, MD, PhD, FACP – National Cancer Institute
Cytokines in Cancer Immunotherapy Virtual Workshop
Oct. 11–12, 2021 · Register Now · Program Schedule
Program Organizers
- Susan M. Kaech, PhD – Salk Institute
- Anne O' Garra, PhD – The Francis Crick Institute
- Aaron Ring, MD, PhD– Yale University
Order Your Copy of Cancer Immunotherapy Principles and Practices, 2nd Ed.
SITC is pleased to announce Cancer Immunotherapy Principles and Practice, 2nd Ed. texbook published
September 1, 2021. The second edition has been thoroughly updated to reflect major advances in the field of immuno-oncology and remains the definitive resource for information on tumor immunology and cancer immunotherapy treatments. New to this edition are chapters with deeper insight into our understanding of adoptive cell therapy, cancer genomics and determinants of response, cancer immune exclusion, cancer and stromal cell-intrinsic pathways of immune resistance, immunogenic cell death, immunotherapy in combination with radiation therapy, metabolomics, tumor mutation burden, synthetic biology, and more. Visit sitcancer.org/CIPPtextbook for more information and to order your copy. Use code SITC20 to receive a 20% discount plus free shipping.